IGFBP7 and esophageal cancer: Utilizing detection techniques such as qRT-PCR, immunohistochemistry, Northern blot, and Western blot, studies have revealed that IGFBP7 expression is generally downregulated in hepatocellular carcinoma, melanoma, and lung cancer, while showing an upregulation trend in esophageal cancer.